留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

幽门螺杆菌相关性慢性萎缩性胃炎与胃癌关系的研究进展

武国兵 程晓龙 于潇 张爱斌 刘敏 陈兆峰

武国兵, 程晓龙, 于潇, 张爱斌, 刘敏, 陈兆峰. 幽门螺杆菌相关性慢性萎缩性胃炎与胃癌关系的研究进展[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2022-0374
引用本文: 武国兵, 程晓龙, 于潇, 张爱斌, 刘敏, 陈兆峰. 幽门螺杆菌相关性慢性萎缩性胃炎与胃癌关系的研究进展[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2022-0374
WU Guobing, CHENG Xiaolong, YU Xiao, ZHANG Aibin, LIU Min, CHEN Zhaofeng. Research Progress on the Relationship Between Helicobacter Pylori Associated Chronic Atrophic Gastritis and Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2022-0374
Citation: WU Guobing, CHENG Xiaolong, YU Xiao, ZHANG Aibin, LIU Min, CHEN Zhaofeng. Research Progress on the Relationship Between Helicobacter Pylori Associated Chronic Atrophic Gastritis and Gastric Cancer[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2022-0374

幽门螺杆菌相关性慢性萎缩性胃炎与胃癌关系的研究进展

doi: 10.12290/xhyxzz.2022-0374
基金项目: 

国家自然科学基金(81960430);甘肃省自然科学基金(21JR1RA073)

详细信息
    通讯作者:

    陈兆峰,E-mail:zhfchen@lzu.edu.cn

  • 中图分类号: R735.2

Research Progress on the Relationship Between Helicobacter Pylori Associated Chronic Atrophic Gastritis and Gastric Cancer

Funds: 

National Natural Science Foundation of China(81960430)

  • 摘要: 幽门螺杆菌相关性慢性萎缩性胃炎(chronic atrophic gastritis,CAG)是胃癌的一种癌前病变,并且可通过多种因素促使胃癌的发生,但具体作用机制尚不明确。本文回顾相关研究进展,探讨幽门螺杆菌相关性CAG在胃癌发生过程中的作用机制,以期为临床医务人员提供参考。
  • [1] Correa P, Piazuelo MB. The gastric precancerous cascade[J]. J Dig Dis, 2012, 13:2-9.
    [2] Conti L, Borro M, Milani C, et al. Gastric microbiota composition in patients with corpus atrophic gastritis[J]. Dig Liver Dis, 2021, 53:1580-1587.
    [3] Yoon JH, Lee YS, Kim O, et al. NKX6.3 protects against gastric mucosal atrophy by downregulating β-amyloid production[J]. World J Gastroenterol, 2019, 25:330-345.
    [4] 尹意婷, 鲁月琴, 何月敏, 等.石斛养胃汤联合奥美拉唑肠溶胶囊对慢性萎缩性胃炎患者炎症因子及氧化应激水平的影响[J]. 新中医, 2022, 54:108-112.
    [5] Tsukanov VV, Smirnova OV, Kasparov EV, et al. Changes in the indices of prooxidant and antioxidant systems in blood plasma in men with atrophic gastritis and gastric cancer[J]. Ter Arkh, 2018, 90:24-27.
    [6] Ndegwa N, Ploner A, Andersson AF, et al. Gastric Microbiota in a Low-Helicobacter pylori Prevalence General Population and Their Associations With Gastric Lesions[J]. Clin Transl Gastroenterol, 2020, 11:e00191.
    [7] Liou JM, Malfertheiner P, Lee YC, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention:the Taipei global consensus[J]. Gut, 2020, 69:2093-2112.
    [8] Sung JJY, Coker OO, Chu E, et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication[J]. Gut, 2020, 69:1572-1580.
    [9] Huang JY, Goers Sweeney E, Guillemin K, et al. Multiple Acid Sensors Control Helicobacter pylori Colonization of the Stomach[J]. PLoS Pathog, 2017, 13:e1006118.
    [10] Loke MF, Ng CG, Vilashni Y, et al. Understanding the dimorphic lifestyles of human gastric pathogen Helicobacter pylori using the SWATH-based proteomics approach[J]. Sci Rep, 2016, 6:26784.
    [11] Pimentel-Nunes P, Barros A, Pita I, et al. Gastric microbiome profile throughout gastric carcinogenesis:beyond helicobacter[J]. Scand J Gastroenterol, 2021, 56:708-716.
    [12] Zhang X, Li C, Cao W, et al. Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages[J]. Front Cell Infect Microbiol, 2021, 11:559148.
    [13] Yu C, Su Z, Li Y, et al. Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats[J]. Biomed Pharmacother, 2020, 126:110036.
    [14] Zhou P, Yang T, Xu M, et al. 16S rRNA sequencing-based evaluation of the protective effects of Hua-Zhuo-Jie-Du on rats with chronic atrophic gastritis[J]. BMC Complement Med Ther, 2022, 22:71.
    [15] Castaño-Rodríguez N, Goh KL, Fock KM, et al. Dysbiosis of the microbiome in gastric carcinogenesis[J]. Sci Rep, 2017, 7:15957.
    [16] 胡嗣基, 毛祖芬.胃的自我保护[J].生物学通报, 2002, 37:23-24.
    [17] Wang YK, Shen L, Yun T, et al. Histopathological classification and follow-up analysis of chronic atrophic gastritis[J]. World J Clin Cases, 2021, 9:3838-3847.
    [18] Caron TJ, Scott KE, Fox JG, et al. Tight junction disruption:Helicobacter pylori and dysregulation of the gastric mucosal barrier[J]. World J Gastroenterol, 2015, 21:11411-11427.
    [19] Shin SY, Kim JH, Chun J, et al. Chronic atrophic gastritis and intestinal metaplasia surrounding diffuse-type gastric cancer:Are they just bystanders in the process of carcinogenesis?[J]. PLoS One, 2019, 14:e0226427.
    [20] Fornasarig M, Capuano A, Maiero S, et al. pCLE highlights distinctive vascular patterns in early gastric cancer and in gastric diseases with high risk of malignant complications[J]. Sci Rep, 2021, 11:21053.
    [21] Capuano A, Andreuzzi E, Pivetta E, et al. The Probe Based Confocal Laser Endomicroscopy (pCLE) in Locally Advanced Gastric Cancer:A Powerful Technique for Real-Time Analysis of Vasculature[J]. Front Oncol, 2019, 9:513.
    [22] Miranti EH, Stolzenberg-Solomon R, Weinstein SJ, et al. Low vitamin B(12) increases risk of gastric cancer:A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer[J]. Int J Cancer, 2017, 141:1120-1129.
    [23] Jiang J, Shen S, Dong N, et al. Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases[J]. Cancer Med, 2018, 7:4068-4076.
    [24] Helge W. Waldum H. Tumor Classification Should Be Based on Biology and Not Consensus:Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer[J]. Cancers (Basel), 2021, 13:3159.
    [25] Wölffling S, Daddi AA, Imai-Matsushima A, et al. EGF and BMPs Govern Differentiation and Patterning in Human Gastric Glands[J]. Gastroenterology, 2021, 161:623-636.
    [26] Rosania R, Varbanova M, Wex T, et al. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer[J]. BMC Gastroenterol, 2017, 17:84.
    [27] 游绍伟, 易旭, 赵琦,等.萎胃通调汤对大鼠慢性萎缩性胃炎癌前病变及IKKβ, Bcl-2表达的影响[J]. 中国实验方剂学杂志, 2021, 27:55-61.
    [28] Dong CX, Deng DJ, Pan KF, et al. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions:a population-based study[J]. Int J Cancer, 2009, 124:434-439.
    [29] Petersen CP, Weis VG, Nam KT, et al. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells[J].Gastroenterology, 2014, 146:1727-1738.
    [30] Xiang P, Chen T, Mou Y, et al. NZ suppresses TLR4/NF-κB signalings and NLRP3 inflammasome activation in LPS-induced RAW264.7 macrophages[J]. Inflamm Res, 2015, 64:799-808.
    [31] 黎慧娟, 陈露, 唐畅宇,等.TLR4/NF-κB/COX-2致炎信号通路对幽门螺杆菌相关性慢性萎缩性胃炎发生、发展的影响及机制研究[J].胃肠病学和肝病学杂志, 2020, 29:773-777.
    [32] Cai Q, Shi P, Yuan Y, et al. Inflammation-Associated Senescence Promotes Helicobacter pylori-Induced Atrophic Gastritis[J]. Cell Mol Gastroenterol Hepatol, 2021, 11:857-880.
    [33] Zhang Z, Fan B, Liu F, et al. HOX transcript antisense RNA is elevated in gastric carcinogenesis and regulated by the NF-κB pathway[J]. J Cell Biochem, 2019, 120:10548-10555.
    [34] Peng Y, Zhao Q, Zhang H, et al. TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling[J]. Oncol Rep, 2016, 35:2480-2486.
    [35] Jeong H, Lee B, Kim KH, et al. WFDC2 Promotes Spasmolytic Polypeptide-Expressing Metaplasia Through the Up-Regulation of IL33 in Response to Injury[J].Gastroenterology, 2021, 161:953-967.
    [36] Osaki LH, Bockerstett KA, Wong CF, et al. Interferon-γ directly induces gastric epithelial cell death and is required for progression to metaplasia[J]. J Pathol, 2019, 247:513-523.
    [37] Rugge M, Genta RM. Staging and grading of chronic gastritis[J]. Hum Pathol, 2005, 36:228-233.
    [38] Maric L, Castaneda D, Singh H, et al. Kimura-Takemoto Classification:A Tool to Predict Gastric Intestinal Metaplasia Progression to Advanced Gastric Neoplasia[J]. Dig Dis Sci, 2022, 67:4092-4099.
    [39] Masuyama H, Yoshitake N, Sasai T, et al. Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk[J]. Digestion, 2015, 91:30-36.
    [40] Rugge M, Sugano K, Scarpignato C, et al. Gastric cancer prevention targeted on risk assessment:Gastritis OLGA staging[J]. Helicobacter, 2019,24:e12571.
    [41] Salazar BE, Pérez-Cala T, Gomez-Villegas SI, et al. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening:a cross-sectional study[J]. Virchows Arch, 2022, 480:759-769.
    [42] Rugge M, Genta RM, Fassan M, et al. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk:A Long-term Follow-up Study of 7436 Patients[J]. Am J Gastroenterol, 2018, 113:1621-1628.
    [43] Piazuelo MB, Bravo LE, Mera RM, et al. The Colombian Chemoprevention Trial:20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions[J]. Gastroenterology, 2021, 160:1106-1117.
    [44] Shichijo S, Hirata Y, Niikura R, et al. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication[J]. Gastrointest Endosc, 2016, 84:618-624.
    [45] Zhang M, Liu S, Hu Y, et al. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions[J]. Sci Rep, 2019, 9:14909.
  • 加载中
计量
  • 文章访问数:  8
  • HTML全文浏览量:  4
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-05-17
  • 录用日期:  2022-07-22
  • 网络出版日期:  2022-08-01

目录

    /

    返回文章
    返回